BioStem Technologies, Inc. (BSEM) Misses Q2 EPS by 131c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts BSEM Hot Sheet
Join SI Premium – FREE
BioStem Technologies, Inc. (OTC: BSEM) reported Q2 EPS of ($0.03), $1.31 worse than the analyst estimate of $1.28. Revenue for the quarter came in at $49.29 million versus the consensus estimate of $102.3 million.
For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robinhood shares fall on Q3 revenue miss even as EPS beats
- BigBear.ai (BBAI) Misses Q3 EPS by 14c; Offers Guidance
- NXP Semiconductors (NXPI) Tops Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
